It has been reported that FoxP3 expression is increased in thyroid cancer, hepatocellular carcinoma, colorectal cancer, cervical cancer and oral squamous cell carcinoma and promotes tumor progression [43–47]. Here, FOXP3 is linked to thyroid gland carcinoma.